Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-14

Clinical Trial Update: Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety of ticagrelor alone versus a combination of lysine acetylsalicylate-clopidogrel in patients undergoing transcatheter aortic valv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)
  • lysine acetylsalicylate-clopidogrel

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Aortic Valve Stenosis | Phase 3 | Status: COMPLETED